Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
What youll learn Youll get a clear breakdown of how GLP-1 medications work, which ones are available, and practical insight into what to expect in terms of benefits and side effects
Shrank WH, et al
Bimagrumab blocks these receptors, disabling the switch and allowing muscles to expand
2025 Feb 5;14(1):18
A retrospective cohort study found that semaglutide use was associated with a 44% reduced risk of incident cannabis use disorder (CUD) in patients with no prior history (hazard ratio [HR]: 0.56, 95% confidence interval [CI]: 0.420.75) and a 38% reduction in recurrent CUD diagnosis (HR: 0.62, 95% CI: 0.460.84) among patients with a prior history, compared to non-GLP-1RA medications [Citation61]
